Skip to main content
PMC home page
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2004 Dec 15;75(2):181–184. doi: 10.1002/jmv.20254

Evaluation of a recombinant nucleocapsid protein‐based assay for Anti‐SARS‐CoV IgG detection

Paul KS Chan 1,2,✉, Esther YM Liu 2, Danny TM Leung 3, Jo LK Cheung 2, CH Ma 3, Frankie CH Tam 3, Mamie Hui 1,2, John S Tam 1,2, Pak Leong Lim 3
PMCID: PMC7166388  PMID: 15602743

Abstract

A high throughput accurate assay for anti‐SARS‐CoV IgG detection is needed for large‐scale epidemiological studies. The evaluation of a commercial recombinant nucleocapsid protein‐based microtitre plate enzyme immunoassay, ELISARS™ is described. The results on 150 sera from SARS patients and 450 sera from non‐SARS controls showed that this assay had a high level of sensitivity (96.2% for late serum samples) and specificity (97.8%). The performance and setup of this assay fulfills the requirement as a screening test for large‐scale studies. A vast majority of SARS patients developed antibodies against the nucleocapsid protein. In some patients (10/45), a high level of anti‐nucleocapsid antibody appeared very early in the course of the illness. In contrast, a minority (4 of 105 patients) never developed these antibodies. The implication of differences in antibody response to the nucleocapsid protein deserves further investigation. J. Med. Virol. 75:181–184, 2005. © 2004 Wiley‐Liss, Inc.

Keywords: coronavirus, diagnosis, enzyme immunoassay, SARS, serology

REFERENCES

  1. Chan PKS, Ng KC, Chan RCW, Lam RKY, Chow VCY, Hui M, Wu A, Lee N, Yap HY, Cheng FW, Sung JJ, Tam JS. 2004a. Immunofluorescence assay for serologic diagnosis of SARS. Emerg Infect Dis 10: 530–532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chan PKS, To WK, Ng KC, Lam RK, Ng TK, Chan RC, Wu A, Yu WC, Lee N, Hui DS, Lai ST, Hon EK, Li CK, Sung JJ, Tam JS. 2004b. Laboratory diagnosis for severe acute respiratory syndrome. Emerg Infect Dis 10: 825–831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chang MS, Lu YT, Ho ST, Wu CC, Wei TY, Chen CJ, Hsu YT, Chu PC, Chen CH, Chu JM, Jan YL, Hung CC, Fan CC, Yang YC. 2004. Antibody detection of SARS‐CoV spike and nucleocapsid protein. Biochem Biophys Res Commun 314: 931–936. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chen X, Zhou B, Li M, Liang X, Wang H, Yang G, Wang H, Le X. 2004. Serology of severe acute respiratory syndrome: Implications for surveillance and outcome. J Infect Dis 189: 1158–1163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Drosten C, Gunther S, Preiser W, van der WS, Brodt HR, Becker S, Rabenau H, Panning M, Kolesnikova L, Fouchier RA, Berger A, Burguiere AM, Cinatl J, Eickmann M, Escriou N, Grywna K, Kramme S, Manuguerra JC, Muller S, Rickerts V, Sturmer M, Vieth S, Klenk HD, Osterhaus AD, Schmitz H, Doerr HW. 2003. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 348: 1967–1976. [DOI] [PubMed] [Google Scholar]
  6. Fouchier RA, Kuiken T, Schutten M, van Amerongen G, van Doornum GJ, van den Hoogen BG, Peiris M, Lim W, Stohr K, Osterhaus AD. 2003. Aetiology: Koch's postulates fulfilled for SARS virus. Nature 423: 240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Guan M, Chen HY, Foo SY, Tan YJ, Goh PY, Wee SH. 2004. Recombinant protein‐based enzyme‐linked immunosorbent assay and immunochromatographic tests for detection of immunoglobulin G antibody to severe acute respiratory syndrome (SARS) coronavirus in SARS patients. Clin Diagn Lab Immunol 11: 287–291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Huang LR, Chiu CM, Yeh SH, Huang WH, Hsueh PR, Yang WZ, Yang JY, Su IJ, Chang SC, Chen PJ. 2004. Evaluation of antibody responses against SARS coronaviral nucleocapsid or spike proteins by immunoblotting or ELISA. J Med Virol 73: 338–346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kim TW, Lee JH, Hung CF, Peng S, Roden R, Wang MC, Viscidi R, Tsai YC, He L, Chen PJ, Boyd DA, Wu TC. 2004. Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus. J Virol 78: 4638–4645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, Tong S, Urbani C, Comer JA, Lim W, Rollin PE, Dowell SF, Ling AE, Humphrey CD, Shieh WJ, Guarner J, Paddock CD, Rota P, Fields B, DeRisi J, Yang JY, Cox N, Hughes JM, LeDuc JW, Bellini WJ, Anderson LJ. 2003. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 348: 1953–1966. [DOI] [PubMed] [Google Scholar]
  11. Kuiken T, Fouchier RAM, Schutten M, Rimmelzwaan GF, van Amerongen G, van Riel D, Laman JD, de Jong T, van Doornum G, Lim W, Ling AE, Chan PKS, Tam JS, Zambon MC, Gopal R, Drosten C, van der WS, Escriou N, Manuguerra JC, Stohr K, Peiris JSM, Osterhaus ADME. 2003. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 362: 263–270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM, Ahuja A, Yung MY, Leung CB, To KF, Lui SF, Szeto CC, Chung S, Sung JJY. 2003. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 348: 1986–1994. [DOI] [PubMed] [Google Scholar]
  13. Leung DT, Tam FC, Ma CH, Chan PK, Cheung JL, Niu H, Tam JS, Lim PK. 2004. Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid. J Infect Dis 190: 379–386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Liu X, Shi Y, Li P, Li L, Yi Y, Ma Q, Cao C. 2004. Profile of antibodies to the nucleocapsid protein of the severe acute respiratory syndrome (SARS)‐associated coronavirus in probable SARS patients. Clin Diagn Lab Immunol 11: 227–228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Peiris JS, Lai ST, Poon LL, Guan Y, Yam LY, Lim W, Nicholls J, Yee WK, Yan WW, Cheung MT, Cheng VC, Chan KH, Tsang DN, Yung RW, Ng TK, Yuen KY. 2003a. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361: 1319–1325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Peiris JS, Chu CM, Cheng VC, Chan KS, Hung IF, Poon LL, Law KI, Tang BS, Hon TY, Chan CS, Chan KH, Ng JS, Zheng BJ, Ng WL, Lai RW, Guan Y, Yuen KY. 2003b. Clinical progression and viral load in a community outbreak of coronavirus‐associated SARS pneumonia: A prospective study. Lancet 361: 1767–1772. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Rainer TH. 2004. Severe acute respiratory syndrome: Clinical features, diagnosis, and management. Curr Opin Pulm Med 10: 159–165. [DOI] [PubMed] [Google Scholar]
  18. Shi Y, Yi Y, Li P, Kuang T, Li L, Dong M, Ma Q, Cao C. 2003. Diagnosis of severe acute respiratory syndrome (SARS) by detection of SARS coronavirus nucleocapsid antibodies in an antigen‐capturing enzyme‐linked immunosorbent assay. J Clin Microbiol 41: 5781–5782. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Timani KA, Ye L, Ye L, Zhu Y, Wu Z, Gong Z. 2004. Cloning, sequencing, expression, and purification of SARS‐associated coronavirus nucleocapsid protein for serodiagnosis of SARS. J Clin Virol 30: 309–312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Wang J, Wen J, Li J, Yin J, Zhu Q, Wang H, Yang Y, Qin E, You B, Li W, Li X, Huang S, Yang R, Zhang X, Yang L, Zhang T, Yin Y, Cui X, Tang X, Wang L, He B, Ma L, Lei T, Zeng C, Fang J, Yu J, Wang J, Yang H, West MB, Bhatnagar A, Lu Y, XU N, Liu S. 2003. Assessment of immunoreactive synthetic peptides for the structural proteins of severe acute respiratory syndrome coronavirus. Clin Chem 49: 1989–1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Woo PC, Lau SK, Wong BH, Tsoi HW, Fung AM, Chan KH, Tam VK, Peiris JS, Yuen KY. 2004a. Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia. J Clin Microbiol 42: 2306–2309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Woo PC, Lau SK, Wong BH, Chan KH, Chu CM, Tsoi HW, Huang Y, Peiris JS, Yuen KY. 2004b. Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus. Clin Diagn Lab Immunol 11: 665–668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. World Health Organization . 2003. Case definitions for surveillance of severe acute respiratory syndrome (SARS). (Accessed on April 20, 2004), available from: URL: http://www.who.int/csr/sars/casedefinition/en/
  24. Zhu MS, Pan Y, Chen HQ, Shen Y, Wang XC, Sun YJ, Tao KH. 2004. Induction of SARS‐nucleoprotein‐specific immune response by use of DNA vaccine. Immunol Lett 92: 237–243. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Medical Virology are provided here courtesy of Wiley

RESOURCES